Lyra Net Invested Capital vs Deferred Long Term Liab Analysis
LYRA Stock | USD 0.38 0 0.37% |
Lyra TherapeuticsInc financial indicator trend analysis is infinitely more than just investigating Lyra TherapeuticsInc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lyra TherapeuticsInc is a good investment. Please check the relationship between Lyra TherapeuticsInc Net Invested Capital and its Deferred Long Term Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyra TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.
Net Invested Capital vs Deferred Long Term Liab
Net Invested Capital vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lyra TherapeuticsInc Net Invested Capital account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Lyra TherapeuticsInc's Net Invested Capital and Deferred Long Term Liab is -0.56. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Lyra TherapeuticsInc, assuming nothing else is changed. The correlation between historical values of Lyra TherapeuticsInc's Net Invested Capital and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Lyra TherapeuticsInc are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Net Invested Capital i.e., Lyra TherapeuticsInc's Net Invested Capital and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | -0.56 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from Lyra TherapeuticsInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lyra TherapeuticsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyra TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.At present, Lyra TherapeuticsInc's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 73.5 M, whereas Selling General Administrative is forecasted to decline to about 12.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 102K | 1.0M | 4.1M | 4.3M | Net Interest Income | 102K | 1.0M | 4.1M | 4.3M |
Lyra TherapeuticsInc fundamental ratios Correlations
Click cells to compare fundamentals
Lyra TherapeuticsInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lyra TherapeuticsInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 15.0M | 80.8M | 54.9M | 110.0M | 142.6M | 78.6M | |
Other Current Liab | 110K | 149K | 4.3M | 9.0M | 9.4M | 9.8M | |
Total Current Liabilities | 5.2M | 4.9M | 18.2M | 14.5M | 19.6M | 11.8M | |
Total Stockholder Equity | 7.3M | 74.5M | 34.3M | 80.8M | 89.4M | 93.9M | |
Net Tangible Assets | (123.3M) | 74.5M | 34.3M | 80.8M | 92.9M | 97.5M | |
Net Debt | (6.5M) | (72.2M) | (44.3M) | (30.3M) | 4.5M | 4.8M | |
Retained Earnings | (127.8M) | (149.9M) | (193.4M) | (248.7M) | (311.4M) | (295.8M) | |
Accounts Payable | 1.1M | 922K | 3.1M | 2.6M | 3.1M | 2.1M | |
Cash | 9.8M | 74.6M | 45.7M | 32.6M | 22.4M | 38.3M | |
Non Current Assets Total | 4.8M | 4.9M | 6.9M | 9.1M | 37.8M | 39.7M | |
Non Currrent Assets Other | 1.1M | 118K | 762K | 3.3M | 1.1M | 1.2M | |
Other Assets | 1.4M | 2.7M | 1.1M | 4.7M | 5.4M | 5.6M | |
Cash And Short Term Investments | 9.8M | 74.6M | 45.7M | 97.9M | 102.8M | 65.0M | |
Common Stock Shares Outstanding | 12.9M | 8.6M | 13.0M | 30.2M | 49.8M | 52.3M | |
Liabilities And Stockholders Equity | 15.0M | 80.8M | 54.9M | 110.0M | 142.6M | 78.6M | |
Non Current Liabilities Total | 2.4M | 1.5M | 2.3M | 14.7M | 33.6M | 24.7M | |
Capital Lease Obligations | 3.3M | 2.4M | 1.5M | 2.2M | 26.9M | 28.2M | |
Other Current Assets | 311K | 1.3M | 2.2M | 2.9M | 2.1M | 1.8M | |
Other Stockholder Equity | 4.4M | 224.4M | 227.7M | 329.4M | 400.7M | 420.7M | |
Total Liab | 7.6M | 6.3M | 20.6M | 29.2M | 53.2M | 33.2M | |
Net Invested Capital | 7.3M | 74.5M | 34.3M | 80.8M | 89.4M | 93.9M | |
Total Current Assets | 10.1M | 75.9M | 47.9M | 100.8M | 104.8M | 66.8M | |
Net Working Capital | 4.9M | 71.0M | 29.7M | 86.4M | 85.2M | 55.0M | |
Property Plant Equipment | 3.4M | 2.2M | 5.9M | 4.5M | 5.1M | 3.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Lyra TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lyra TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lyra Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lyra Therapeuticsinc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyra TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Lyra Stock analysis
When running Lyra TherapeuticsInc's price analysis, check to measure Lyra TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lyra TherapeuticsInc is operating at the current time. Most of Lyra TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Lyra TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lyra TherapeuticsInc's price. Additionally, you may evaluate how the addition of Lyra TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stocks Directory Find actively traded stocks across global markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Lyra TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyra TherapeuticsInc. If investors know Lyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyra TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share 0.03 | Quarterly Revenue Growth 0.298 | Return On Assets (0.38) | Return On Equity (0.96) |
The market value of Lyra TherapeuticsInc is measured differently than its book value, which is the value of Lyra that is recorded on the company's balance sheet. Investors also form their own opinion of Lyra TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Lyra TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyra TherapeuticsInc's market value can be influenced by many factors that don't directly affect Lyra TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyra TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyra TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyra TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.